相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mixed myeloid chimerism and relapse of myelofibrosis after allogeneic stem cell transplantation
Samer A. Srour et al.
HAEMATOLOGICA (2021)
Determinants of survival in myelofibrosis patients undergoing allogeneic hematopoietic cell transplantation
Juan Carlos Hernandez-Boluda et al.
LEUKEMIA (2021)
Impact of spleen size and splenectomy on outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis: A retrospective analysis by the chronic malignancies working party on behalf of European society for blood and marrow transplantation (EBMT)
Nicola Polverelli et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party
Donal P. McLornan et al.
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE (2021)
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study
Damien Luque Paz et al.
BLOOD ADVANCES (2021)
Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT
Bhagirathbhai Dholaria et al.
HAEMATOLOGICA (2020)
Predictors of recovery following allogeneic CD34+-selected cell infusion without conditioning to correct poor graft function
Maria M. Cuadrado et al.
HAEMATOLOGICA (2020)
Targeted Sequencing Improves DIPSS-Plus Prognostic Scoring in Myelofibrosis Patients Undergoing Allogeneic Transplantation
Emily A. Stevens et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis
Tania Jain et al.
BLOOD CANCER JOURNAL (2020)
Early Mixed Lymphoid Donor/Host Chimerism is Associated with Improved Transplant Outcome in Patients with Primary or Secondary Myelo fibrosis
H. Joachim Deeg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Incidence and Outcome of Late Relapse after Allogeneic Stem Cell Transplantation for Myelofibrosis
Isik Kaygusuz Atagunduz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)
Treosulfan-Based Conditioning Regimen for Second Allograft in Patients with Myelofibrosis
Isik Kaygusuz Atagunduz et al.
CANCERS (2020)
Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation
Nico Gagelmann et al.
BLOOD (2019)
State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019
Donal P. McLornan et al.
HAEMATOLOGICA (2019)
Incidence, Risk Factors, and Outcomes of Primary Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
Yanmin Zhao et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Myeloablative and Reduced-Intensity Conditioned Allogeneic Hematopoietic Stem Cell Transplantation in Myelofibrosis: A Retrospective Study by the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation
Donal McLornan et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Impact of High-Molecular-Risk Mutations on Transplantation Outcomes in Patients with Myelofibrosis
Roni Tamari et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Donor Lymphocyte Infusions (DLI): Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
John De Vos et al.
BULLETIN DU CANCER (2019)
Outcomes Following Second Allogenic Haematopoietic Cell Transplantation in Patients with Myelofibrosis: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of EBMT
Mitja Nabergoj et al.
BLOOD (2019)
MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen
Haris Ali et al.
BLOOD ADVANCES (2019)
Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT
Donal P. McLornan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients
Ayalew Tefferi et al.
LEUKEMIA (2018)
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
J. Grinfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Impact of molecular residual disease post allografting in myelofibrosis patients
C. Wolschke et al.
BONE MARROW TRANSPLANTATION (2017)
Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation
Nicolaus Kroeger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Real Time PCR Detects Relapse of JAK2 V617F Myelofibrosis Earlier Than Pyrosequencing after Allogeneic Transplantation
Mithun Vinod Shah et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Problems and pitfalls in grading of bone marrow fibrosis, collagen deposition and osteosclerosis - a consensus-based study
Hans Michael Kvasnicka et al.
HISTOPATHOLOGY (2016)
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Chronic and Advanced Phase Myelofibrosis
Alla Keyzner et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
Daniel A. Arber et al.
BLOOD (2016)
Incidence and risk factors of poor graft function after allogeneic stem cell transplantation for myelofibrosis
H. Alchalby et al.
BONE MARROW TRANSPLANTATION (2016)
Ruxolitinib for Myelofibrosis Patients Relapsing after Allogeneic Hematopoietic Transplantation
Dietlinde Janson et al.
BLOOD (2016)
Allo-SCT for myelofibrosis: reversing the chronic phase in the JAK inhibitor era?
R. Tamari et al.
BONE MARROW TRANSPLANTATION (2015)
Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
N. M. Kroeger et al.
LEUKEMIA (2015)
CD34+-Selected Stem Cell Boost without Further Conditioning for Poor Graft Function after Allogeneic Stem Cell Transplantation in Patients with Hematological Malignancies
Evgeny Klyuchnikov et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
CD34 Selected Cells for the Treatment of Poor Graft Function after Allogeneic Stem Cell Transplantation
Alessandra Stasia et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Dynamic of Bone Marrow Fibrosis Regression Predicts Survival after Allogeneic Stem Cell Transplantation for Myelofibrosis
Nicolaus Kroeger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Revised response criteria for myelofibrosis: International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus report
Ayalew Tefferi et al.
BLOOD (2013)
Graft failure in the modern era of allogeneic hematopoietic SCT
R. Olsson et al.
BONE MARROW TRANSPLANTATION (2013)
Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
Anthony J. Bench et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse
Thoralf Lange et al.
HAEMATOLOGICA (2013)
Donor lymphocyte infusions and second transplantation as salvage treatment for relapsed myelofibrosis after reduced-intensity allografting
Evgeny Klyuchnikov et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Clinical options after failure of allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies
Aleksandra Petrovic et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2011)
Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis
Marie Robin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
JAK2-V617F-triggered preemptive and salvage adoptive immunotherapy with donor-lymphocyte infusion in patients with myelofibrosis after allogeneic stem cell transplantation
Nicolaus Kroeger et al.
BLOOD (2009)
Regression of myelofibrosis and osteosclerosis following hematopoietic cell transplantation assessed by magnetic resonance imaging and histologic grading
George E. Sale et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2006)
Dose-escalated donor lymphocyte inftisions following reduced intensity transplantation: toxicity, chimerism, and disease responses
KS Peggs et al.
BLOOD (2004)
Mini-review - Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation
SN Wolff
BONE MARROW TRANSPLANTATION (2002)
Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation: demonstration of a graft-versus-myelofibrosis effect
F Cervantes et al.
BONE MARROW TRANSPLANTATION (2000)
分享论文
